Synoptical view

    Truffle investment
    € 9M
carbios_principale.jpg

Management team

Board of Directors

President Emmanuel Macron congratulates Carbios on the 2nd anniversary of France 2030, Vexim (MedTech acquired by Stricker for $200 million), Carmat, Symetis (MedTech acquired by Boston Scientific for $430 million), Affluent Medical (MedTech, listed on the stock exchange), Diaccurate and Caranx Medical.

As a former Paris hospital intern in immunology and hematology, Dr Pouletty holds a doctorate in medicine from the University of Paris VI and a master's degree in immunology and virology from the Institut Pasteur. He was a post-doctoral researcher (1986-1988) at Stanford University.

He is the winner of the 1999 American Liver Foundation Award. Doctor Philippe Pouletty is a Chevalier de la Légion d'Honneur.

">
philippe_pouletty.jpg

Philippe Pouletty, M.D.

Chairman

Partners

loreal.jpg nestle.jpg pepsico.jpg suntory.jpg

In summary

Carbios is a green chemistry company producing innovative industrial bioprocesses for the biodegradation and biorecycling of plastic and textile polymers.

In particular, Carbios has achieved a world first, with the 100% recycling of a PET bottle (coca cola type) paving the way for a truly circular plastics economy.

In video

They talk about it

Carbios' major innovation is to use an enzyme, a biological material, that will depolymerize the plastic. 97% of PET can be depolymerized in just 16 hours. We get a zero waste plastic, explains Alain Marty, scientific director of the company located near Clermont-Ferrand.

Carbios can become the world technological leader in plastics recycling, making political and ecological objectives an industrial reality, helping to clean up our planet, and reducing the use of hydrocarbons to make plastics.

News

Media

carmat_2018_07_17_nb_0179.jpg

Next start-up

Carmat